Seattle Children's Hospital at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Seattle Children's Hospital brings 4 presentations to ASH 2026 in New Orleans. Its program centres on pediatric leukemia and sickle cell care. Sessions cover how to treat ALL, chemo-immunotherapy in children and transfusion reactions in sickle cell disease.
| Organization | ASH 2026 Attendance |
|---|---|
Seattle Children's Hospital Seattle, WA | |
Pediatric hospital and research institute in Seattle, Washington. | Talk Sat Dec 12 8:00am–9:00am Poster Sat Dec 12 5:30pm–7:30pm Talk Sun Dec 13 4:30pm–5:45pm Immune-Mediated Transfusion Reactions in Sickle Cell Disease: A Practical Approach Telling apart hyperhemolysis and delayed hemolytic transfusion reactions in sickle cell disease, and why it matters for prognosis, future transfusions and treatment. Talk Mon Dec 14 10:30am–11:45am Next Steps for Treatment of Pediatric ALL in the Era of Frontline Chemo-Immunotherapy Whether adding inotuzumab or CAR-T to frontline treatment of childhood B-cell acute lymphoblastic leukemia can safely reduce chemotherapy and its toxicity. Session Mon Dec 14 10:30am–11:45am The Golden Era of ALL Management: Rapid Advances Across the Age Spectrum How blinatumomab, CAR-T cells and other immunotherapies are reshaping acute lymphoblastic leukemia care and reducing chemotherapy across all ages. |
Find decision makers at Seattle Children's Hospital
Tell us what you sell and we’ll find the people at Seattle Children's Hospital most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction